Zobrazeno 1 - 10
of 256
pro vyhledávání: '"Naveed Sattar"'
Autor:
John M Dennis, Katherine G Young, Andrew P McGovern, Bilal A Mateen, Sebastian J Vollmer, Michael D Simpson, William E Henley, Rury R Holman, Naveed Sattar, Ewan R Pearson, Andrew T Hattersley, Angus G Jones, Beverley M Shields
Publikováno v:
The Lancet Digital Health. 4:e873-e883
Current treatment guidelines do not provide recommendations to support the selection of treatment for most people with type 2 diabetes. We aimed to develop and validate an algorithm to allow selection of optimal treatment based on glycaemic response,
Autor:
Thore Buergel, Jakob Steinfeldt, Greg Ruyoga, Maik Pietzner, Daniele Bizzarri, Dina Vojinovic, Julius Upmeier zu Belzen, Lukas Loock, Paul Kittner, Lara Christmann, Noah Hollmann, Henrik Strangalies, Jana M. Braunger, Benjamin Wild, Scott T. Chiesa, Joachim Spranger, Fabian Klostermann, Erik B. van den Akker, Stella Trompet, Simon P. Mooijaart, Naveed Sattar, J. Wouter Jukema, Birgit Lavrijssen, Maryam Kavousi, Mohsen Ghanbari, Mohammad A. Ikram, Eline Slagboom, Mika Kivimaki, Claudia Langenberg, John Deanfield, Roland Eils, Ulf Landmesser
Publikováno v:
Nature Medicine. NATURE PORTFOLIO
Nature Medicine
Nature Medicine, 28(11), 2309-2320. Nature Publishing Group
Nature Medicine, 28(11)
Nature Medicine
Nature Medicine, 28(11), 2309-2320. Nature Publishing Group
Nature Medicine, 28(11)
Publisher Copyright: © 2022, The Author(s). Risk stratification is critical for the early identification of high-risk individuals and disease prevention. Here we explored the potential of nuclear magnetic resonance (NMR) spectroscopy-derived metabol
Autor:
Archana Sharma, Sindre Lee-Ødegård, Elisabeth Qvigstad, Christine Sommer, Naveed Sattar, Jason M.R. Gill, Hanne L. Gulseth, Stina T. Sollid, Ingrid Nermoen, Kåre I. Birkeland
Publikováno v:
Diabetes
South Asian women have a higher risk of type 2 diabetes after gestational diabetes mellitus (GDM) than Nordic women; however, the mechanisms behind this difference remain unclear. We investigated insulin sensitivity, β-cell function, and hepatic ins
Autor:
Janita Halminen, Naveed Sattar, Araz Rawshani, Björn Eliasson, Katarina Eeg-Olofsson, Deepak L. Bhatt, Aidin Rawshani
Publikováno v:
Diabetes Care. 45:2326-2335
OBJECTIVE To investigate trends, optimal levels for cardiometabolic risk factors, and multifactorial risk control in diabetic nephropathy and end-stage kidney disease (ESKD) in patients with diabetes and matched control subjects. RESEARCH DESIGN AND
Autor:
Araz Rawshani, Naveed Sattar, Darren K. McGuire, Oskar Wallström, Ulf Smith, Jan Borén, Göran Bergström, Elmir Omerovic, Annika Rosengren, Björn Eliasson, Deepak L. Bhatt, Aidin Rawshani
Publikováno v:
Circulation. 146:398-411
Background: The role of diabetes in the development of valvular heart disease, and, in particular, the relation with risk factor control, has not been extensively studied. Methods: We included 715 143 patients with diabetes registered in the Swedish
Publikováno v:
Diabetes, Obesity and Metabolism. 24:1607-1616
To evaluate the time-varying cardio-protective effect of glucagon-like peptide-1 receptor agonists (GLP-1RAs) using pooled data from eight contemporary cardiovascular outcome trials using the difference in the restricted mean survival time (ΔRMST) a
Autor:
Naomi Holman, Sarah H. Wild, Kamlesh Khunti, Peter Knighton, Jackie O’Keefe, Chirag Bakhai, Bob Young, Naveed Sattar, Jonathan Valabhji, Edward W. Gregg
Publikováno v:
Holman, N, Wild, S H, Khunti, K, Knighton, P, O'Keefe, J, Bakhai, C, Young, B, Sattar, N A, Valabhji, J & Gregg, E W 2022, ' Incidence and characteristics of remission of type 2 diabetes in England : A cohort study using the National Diabetes Audit ', Diabetes Care, vol. 45, no. 5, pp. 1151-1161 . https://doi.org/10.2337/dc21-2136
Diabetes Care
Diabetes Care
OBJECTIVE To assess the incidence of remission of type 2 diabetes in routine care settings. RESEARCH DESIGN AND METHODS People with type 2 diabetes (HbA1c ≥48 mmol/mol [6.5%] or RESULTS In 2,297,700 people with type 2 diabetes, the overall incidenc
Autor:
Jan Westerink, Kasper Sommer Matthiessen, Solomon Nuhoho, Udi Fainberg, Michael Lyng Wolden, Helena Bleken Østergaard, Frank Visseren, Naveed Sattar
Publikováno v:
Diabetes Care
OBJECTIVE Semaglutide, a glucagon-like peptide 1 receptor agonist, reduced major adverse cardiovascular events (MACE) in people with type 2 diabetes (T2D) at high risk of cardiovascular disease (CVD) in a post hoc analysis of pooled data from Trial t
Autor:
Moneeza K. Siddiqui, Ranjit Mohan Anjana, Adem Y. Dawed, Cyrielle Martoeau, Sundararajan Srinivasan, Jebarani Saravanan, Sathish K. Madanagopal, Alasdair Taylor, Samira Bell, Abirami Veluchamy, Rajendra Pradeepa, Naveed Sattar, Radha Venkatesan, Colin N. A. Palmer, Ewan R. Pearson, Viswanathan Mohan
Publikováno v:
Diabetologia. 65:973-983
Aims/hypothesis South Asians in general, and Asian Indians in particular, have higher risk of type 2 diabetes compared with white Europeans, and a younger age of onset. The reasons for the younger age of onset in relation to obesity, beta cell functi
Autor:
Renato D. Lopes, Naveed Sattar, Hertzel C. Gerstein, Carolyn S.P. Lam, Kelley R. Branch, Seungjae Baek, Elisabeth Niemoeller, Julio Rosenstock, Nardev S. Khurmi, Stefano Del Prato, Chinthanie Ramasundarahettige, Richard E. Pratley
Publikováno v:
Circulation. 145:565-574
Background: Both sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide-1 receptor agonists reduce cardiovascular events among patients with type 2 diabetes. However, no cardiovascular outcome trial has evaluated the long-term ef